Jupiter Research Capital (Asia) Ltd’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.83M Buy
7,627
+1,053
+16% +$1.24M 0.97% 20
2026
Q2
$7.89M Buy
+6,574
New +$6.72M 0.88% 20

Other funds holding LLY

Jupiter Research Capital (Asia) Ltd's LLY Position: Q3 2026 in Review

Jupiter Research Capital (Asia) Ltd increased its Eli Lilly (LLY) stake by 16% in Q3 2026, buying an estimated $1.24M and bringing the position to 7,627 shares worth $8.83M. The position accounts for 0.97% of the portfolio, ranked #20.

Jupiter Research Capital (Asia) Ltd first reported a position in LLY in Q2 2026 and has held it in 2 quarters since. 4,424 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Jupiter Research Capital (Asia) Ltd held 7,627 shares of Eli Lilly worth $8.83M as of Q3 2026.
  • Jupiter Research Capital (Asia) Ltd bought 1,053 Eli Lilly shares in Q3 2026, an estimated $1.24M.
  • Eli Lilly made up 0.97% of Jupiter Research Capital (Asia) Ltd's portfolio in Q3 2026, its #20 holding.
  • Jupiter Research Capital (Asia) Ltd first reported a position in Eli Lilly in Q2 2026 and has held it in 2 quarters since.
  • 4,424 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.